nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—CYP3A5—Gefitinib—lung cancer	0.051	0.0835	CbGbCtD
Fluticasone Propionate—CYP3A5—Teniposide—lung cancer	0.0495	0.0809	CbGbCtD
Fluticasone Propionate—CYP3A7—Paclitaxel—lung cancer	0.0368	0.0602	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0368	0.0602	CbGbCtD
Fluticasone Propionate—CYP3A7—Irinotecan—lung cancer	0.0363	0.0594	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0363	0.0594	CbGbCtD
Fluticasone Propionate—CYP3A5—Crizotinib—lung cancer	0.0313	0.0512	CbGbCtD
Fluticasone Propionate—CYP3A5—Erlotinib—lung cancer	0.0302	0.0494	CbGbCtD
Fluticasone Propionate—CYP3A5—Paclitaxel—lung cancer	0.0276	0.0452	CbGbCtD
Fluticasone Propionate—CYP3A5—Irinotecan—lung cancer	0.0272	0.0446	CbGbCtD
Fluticasone Propionate—CYP3A7—Docetaxel—lung cancer	0.0266	0.0435	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0266	0.0435	CbGbCtD
Fluticasone Propionate—CYP3A5—Etoposide—lung cancer	0.0218	0.0357	CbGbCtD
Fluticasone Propionate—CYP3A4—Topotecan—lung cancer	0.0217	0.0356	CbGbCtD
Fluticasone Propionate—CYP3A5—Docetaxel—lung cancer	0.02	0.0327	CbGbCtD
Fluticasone Propionate—CYP3A4—Gefitinib—lung cancer	0.0199	0.0325	CbGbCtD
Fluticasone Propionate—CYP3A4—Teniposide—lung cancer	0.0193	0.0316	CbGbCtD
Fluticasone Propionate—CYP3A4—Vinorelbine—lung cancer	0.0153	0.0251	CbGbCtD
Fluticasone Propionate—CYP3A4—Crizotinib—lung cancer	0.0122	0.02	CbGbCtD
Fluticasone Propionate—CYP3A4—Erlotinib—lung cancer	0.0118	0.0192	CbGbCtD
Fluticasone Propionate—CYP3A4—Paclitaxel—lung cancer	0.0108	0.0176	CbGbCtD
Fluticasone Propionate—CYP3A4—Irinotecan—lung cancer	0.0106	0.0174	CbGbCtD
Fluticasone Propionate—CYP3A4—Vinblastine—lung cancer	0.00944	0.0155	CbGbCtD
Fluticasone Propionate—CYP3A4—Etoposide—lung cancer	0.00851	0.0139	CbGbCtD
Fluticasone Propionate—CYP3A4—Docetaxel—lung cancer	0.00778	0.0127	CbGbCtD
Fluticasone Propionate—CYP3A4—Doxorubicin—lung cancer	0.0058	0.00949	CbGbCtD
Fluticasone Propionate—PLA2G4A—Raltitrexed—Pemetrexed—lung cancer	0.00457	0.765	CbGdCrCtD
Fluticasone Propionate—Amcinonide—ANXA1—lung cancer	0.00202	0.432	CrCbGaD
Fluticasone Propionate—PGR—mammary gland—lung cancer	0.00198	0.0756	CbGeAlD
Fluticasone Propionate—PLA2G4A—respiratory system—lung cancer	0.00174	0.0666	CbGeAlD
Fluticasone Propionate—SERPINA6—respiratory system—lung cancer	0.00174	0.0663	CbGeAlD
Fluticasone Propionate—PLA2G4A—bronchus—lung cancer	0.00143	0.0548	CbGeAlD
Fluticasone Propionate—PLA2G4A—Raltitrexed—Methotrexate—lung cancer	0.00141	0.235	CbGdCrCtD
Fluticasone Propionate—PGR—respiratory system—lung cancer	0.00132	0.0503	CbGeAlD
Fluticasone Propionate—PLA2G4A—trachea—lung cancer	0.00129	0.0492	CbGeAlD
Fluticasone Propionate—NR3C2—bronchus—lung cancer	0.00117	0.0446	CbGeAlD
Fluticasone Propionate—PGR—epithelium—lung cancer	0.0011	0.0421	CbGeAlD
Fluticasone Propionate—NR3C2—trachea—lung cancer	0.00105	0.04	CbGeAlD
Fluticasone Propionate—PLA2G4A—bone marrow—lung cancer	0.00102	0.039	CbGeAlD
Fluticasone Propionate—SERPINA6—bone marrow—lung cancer	0.00102	0.0389	CbGeAlD
Fluticasone Propionate—NR3C2—cardiac atrium—lung cancer	0.000984	0.0376	CbGeAlD
Fluticasone Propionate—PLA2G4A—lung—lung cancer	0.000926	0.0354	CbGeAlD
Fluticasone Propionate—SERPINA6—lung—lung cancer	0.000922	0.0352	CbGeAlD
Fluticasone Propionate—CYP3A5—respiratory system—lung cancer	0.000766	0.0293	CbGeAlD
Fluticasone Propionate—NR3C1—respiratory system—lung cancer	0.00076	0.0291	CbGeAlD
Fluticasone Propionate—NR3C2—lung—lung cancer	0.000753	0.0288	CbGeAlD
Fluticasone Propionate—PGR—lung—lung cancer	0.0007	0.0267	CbGeAlD
Fluticasone Propionate—NR3C1—epithelium—lung cancer	0.000635	0.0243	CbGeAlD
Fluticasone Propionate—Dexamethasone—ANXA1—lung cancer	0.000635	0.136	CrCbGaD
Fluticasone Propionate—PLA2G4A—lymph node—lung cancer	0.000633	0.0242	CbGeAlD
Fluticasone Propionate—NR3C1—bronchus—lung cancer	0.000626	0.0239	CbGeAlD
Fluticasone Propionate—NR3C1—trachea—lung cancer	0.000562	0.0215	CbGeAlD
Fluticasone Propionate—NR3C1—cardiac atrium—lung cancer	0.000528	0.0202	CbGeAlD
Fluticasone Propionate—NR3C2—lymph node—lung cancer	0.000515	0.0197	CbGeAlD
Fluticasone Propionate—PGR—lymph node—lung cancer	0.000479	0.0183	CbGeAlD
Fluticasone Propionate—NR3C1—bone marrow—lung cancer	0.000446	0.017	CbGeAlD
Fluticasone Propionate—CYP3A5—lung—lung cancer	0.000407	0.0155	CbGeAlD
Fluticasone Propionate—NR3C1—lung—lung cancer	0.000404	0.0154	CbGeAlD
Fluticasone Propionate—Clobetasol propionate—CYP1A1—lung cancer	0.000365	0.0779	CrCbGaD
Fluticasone Propionate—NR3C1—lymph node—lung cancer	0.000276	0.0106	CbGeAlD
Fluticasone Propionate—Fluticasone furoate—ABCB1—lung cancer	0.000226	0.0484	CrCbGaD
Fluticasone Propionate—Dexamethasone—CYP2A6—lung cancer	0.000195	0.0416	CrCbGaD
Fluticasone Propionate—Methylprednisolone—ABCB1—lung cancer	0.000181	0.0386	CrCbGaD
Fluticasone Propionate—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.00018	0.000828	CcSEcCtD
Fluticasone Propionate—Tachycardia—Cisplatin—lung cancer	0.000179	0.000827	CcSEcCtD
Fluticasone Propionate—Rash—Erlotinib—lung cancer	0.000179	0.000825	CcSEcCtD
Fluticasone Propionate—Triamcinolone—PTGS2—lung cancer	0.000179	0.0383	CrCbGaD
Fluticasone Propionate—Dermatitis—Erlotinib—lung cancer	0.000179	0.000824	CcSEcCtD
Fluticasone Propionate—Palpitations—Paclitaxel—lung cancer	0.000179	0.000824	CcSEcCtD
Fluticasone Propionate—Skin disorder—Cisplatin—lung cancer	0.000179	0.000823	CcSEcCtD
Fluticasone Propionate—Hypertension—Etoposide—lung cancer	0.000178	0.000821	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Docetaxel—lung cancer	0.000178	0.00082	CcSEcCtD
Fluticasone Propionate—Headache—Erlotinib—lung cancer	0.000178	0.00082	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Docetaxel—lung cancer	0.000178	0.000818	CcSEcCtD
Fluticasone Propionate—Asthma—Methotrexate—lung cancer	0.000177	0.000818	CcSEcCtD
Fluticasone Propionate—Cough—Paclitaxel—lung cancer	0.000177	0.000814	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Docetaxel—lung cancer	0.000176	0.000811	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Gemcitabine—lung cancer	0.000176	0.00081	CcSEcCtD
Fluticasone Propionate—Chest pain—Etoposide—lung cancer	0.000176	0.00081	CcSEcCtD
Fluticasone Propionate—Nausea—Vinblastine—lung cancer	0.000176	0.000809	CcSEcCtD
Fluticasone Propionate—Hypertension—Paclitaxel—lung cancer	0.000175	0.000805	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000175	0.000804	CcSEcCtD
Fluticasone Propionate—Dexamethasone—ABCG2—lung cancer	0.000174	0.0372	CrCbGaD
Fluticasone Propionate—Pruritus—Vinorelbine—lung cancer	0.000174	0.000801	CcSEcCtD
Fluticasone Propionate—Discomfort—Etoposide—lung cancer	0.000174	0.0008	CcSEcCtD
Fluticasone Propionate—Pain—Irinotecan—lung cancer	0.000173	0.000798	CcSEcCtD
Fluticasone Propionate—Mental disorder—Docetaxel—lung cancer	0.000173	0.000795	CcSEcCtD
Fluticasone Propionate—Arthralgia—Paclitaxel—lung cancer	0.000172	0.000794	CcSEcCtD
Fluticasone Propionate—Chest pain—Paclitaxel—lung cancer	0.000172	0.000794	CcSEcCtD
Fluticasone Propionate—Anxiety—Paclitaxel—lung cancer	0.000172	0.000791	CcSEcCtD
Fluticasone Propionate—Face oedema—Doxorubicin—lung cancer	0.000172	0.000791	CcSEcCtD
Fluticasone Propionate—Erythema—Docetaxel—lung cancer	0.000172	0.00079	CcSEcCtD
Fluticasone Propionate—Malnutrition—Docetaxel—lung cancer	0.000172	0.00079	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000171	0.000788	CcSEcCtD
Fluticasone Propionate—Nausea—Topotecan—lung cancer	0.000171	0.000786	CcSEcCtD
Fluticasone Propionate—Discomfort—Paclitaxel—lung cancer	0.00017	0.000784	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Methotrexate—lung cancer	0.00017	0.000784	CcSEcCtD
Fluticasone Propionate—Pain—Gemcitabine—lung cancer	0.000169	0.000777	CcSEcCtD
Fluticasone Propionate—Nausea—Erlotinib—lung cancer	0.000169	0.000777	CcSEcCtD
Fluticasone Propionate—Dry mouth—Paclitaxel—lung cancer	0.000169	0.000776	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Etoposide—lung cancer	0.000168	0.000776	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Vinorelbine—lung cancer	0.000168	0.000774	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000168	0.000772	CcSEcCtD
Fluticasone Propionate—Infection—Etoposide—lung cancer	0.000167	0.000771	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Irinotecan—lung cancer	0.000167	0.000769	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Irinotecan—lung cancer	0.000166	0.000763	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Paclitaxel—lung cancer	0.000165	0.000761	CcSEcCtD
Fluticasone Propionate—Oedema—Paclitaxel—lung cancer	0.000165	0.000761	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Docetaxel—lung cancer	0.000165	0.00076	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Methotrexate—lung cancer	0.000165	0.00076	CcSEcCtD
Fluticasone Propionate—Tachycardia—Etoposide—lung cancer	0.000164	0.000758	CcSEcCtD
Fluticasone Propionate—Infection—Paclitaxel—lung cancer	0.000164	0.000756	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Cisplatin—lung cancer	0.000164	0.000755	CcSEcCtD
Fluticasone Propionate—Skin disorder—Etoposide—lung cancer	0.000164	0.000754	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Gemcitabine—lung cancer	0.000163	0.000749	CcSEcCtD
Fluticasone Propionate—Dizziness—Vinorelbine—lung cancer	0.000162	0.000748	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Paclitaxel—lung cancer	0.000162	0.000746	CcSEcCtD
Fluticasone Propionate—Tachycardia—Paclitaxel—lung cancer	0.000161	0.000743	CcSEcCtD
Fluticasone Propionate—Skin disorder—Paclitaxel—lung cancer	0.00016	0.000739	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Irinotecan—lung cancer	0.00016	0.000738	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Irinotecan—lung cancer	0.00016	0.000738	CcSEcCtD
Fluticasone Propionate—Pneumonia—Methotrexate—lung cancer	0.000159	0.000733	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Doxorubicin—lung cancer	0.000159	0.000732	CcSEcCtD
Fluticasone Propionate—Infestation—Methotrexate—lung cancer	0.000158	0.000729	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Methotrexate—lung cancer	0.000158	0.000729	CcSEcCtD
Fluticasone Propionate—Pain—Cisplatin—lung cancer	0.000157	0.000725	CcSEcCtD
Fluticasone Propionate—Vomiting—Vinorelbine—lung cancer	0.000156	0.000719	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Gemcitabine—lung cancer	0.000156	0.000719	CcSEcCtD
Fluticasone Propionate—Rash—Vinorelbine—lung cancer	0.000155	0.000713	CcSEcCtD
Fluticasone Propionate—Dermatitis—Vinorelbine—lung cancer	0.000155	0.000713	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Doxorubicin—lung cancer	0.000155	0.000713	CcSEcCtD
Fluticasone Propionate—Headache—Vinorelbine—lung cancer	0.000154	0.000709	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Methotrexate—lung cancer	0.000154	0.000709	CcSEcCtD
Fluticasone Propionate—Asthma—Doxorubicin—lung cancer	0.000154	0.000708	CcSEcCtD
Fluticasone Propionate—Palpitations—Docetaxel—lung cancer	0.000152	0.000698	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Cisplatin—lung cancer	0.000152	0.000698	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00015	0.000693	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Etoposide—lung cancer	0.00015	0.000692	CcSEcCtD
Fluticasone Propionate—Cough—Docetaxel—lung cancer	0.00015	0.00069	CcSEcCtD
Fluticasone Propionate—Epistaxis—Methotrexate—lung cancer	0.000149	0.000688	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Irinotecan—lung cancer	0.000149	0.000688	CcSEcCtD
Fluticasone Propionate—Hypertension—Docetaxel—lung cancer	0.000148	0.000682	CcSEcCtD
Fluticasone Propionate—Bronchitis—Doxorubicin—lung cancer	0.000148	0.000681	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Paclitaxel—lung cancer	0.000147	0.000679	CcSEcCtD
Fluticasone Propionate—Betamethasone—PTGS2—lung cancer	0.000147	0.0313	CrCbGaD
Fluticasone Propionate—Arthralgia—Docetaxel—lung cancer	0.000146	0.000673	CcSEcCtD
Fluticasone Propionate—Chest pain—Docetaxel—lung cancer	0.000146	0.000673	CcSEcCtD
Fluticasone Propionate—Nausea—Vinorelbine—lung cancer	0.000146	0.000672	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Cisplatin—lung cancer	0.000145	0.00067	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000145	0.000668	CcSEcCtD
Fluticasone Propionate—Pain—Etoposide—lung cancer	0.000144	0.000664	CcSEcCtD
Fluticasone Propionate—Dry mouth—Docetaxel—lung cancer	0.000143	0.000658	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000143	0.000658	CcSEcCtD
Fluticasone Propionate—Pain—Paclitaxel—lung cancer	0.000141	0.000651	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Methotrexate—lung cancer	0.000141	0.000649	CcSEcCtD
Fluticasone Propionate—Oedema—Docetaxel—lung cancer	0.00014	0.000645	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Docetaxel—lung cancer	0.00014	0.000645	CcSEcCtD
Fluticasone Propionate—Pruritus—Gemcitabine—lung cancer	0.00014	0.000643	CcSEcCtD
Fluticasone Propionate—Infection—Docetaxel—lung cancer	0.000139	0.000641	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Etoposide—lung cancer	0.000139	0.00064	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Doxorubicin—lung cancer	0.000139	0.000639	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Irinotecan—lung cancer	0.000139	0.000638	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP2E1—lung cancer	0.000138	0.0296	CrCbGaD
Fluticasone Propionate—Pneumonia—Doxorubicin—lung cancer	0.000138	0.000635	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Etoposide—lung cancer	0.000138	0.000635	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Docetaxel—lung cancer	0.000137	0.000633	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Doxorubicin—lung cancer	0.000137	0.000631	CcSEcCtD
Fluticasone Propionate—Infestation—Doxorubicin—lung cancer	0.000137	0.000631	CcSEcCtD
Fluticasone Propionate—Tachycardia—Docetaxel—lung cancer	0.000137	0.00063	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP1A1—lung cancer	0.000136	0.0292	CrCbGaD
Fluticasone Propionate—Feeling abnormal—Paclitaxel—lung cancer	0.000136	0.000627	CcSEcCtD
Fluticasone Propionate—Skin disorder—Docetaxel—lung cancer	0.000136	0.000627	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Cisplatin—lung cancer	0.000135	0.000624	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Paclitaxel—lung cancer	0.000135	0.000622	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Gemcitabine—lung cancer	0.000135	0.000622	CcSEcCtD
Fluticasone Propionate—Dizziness—Irinotecan—lung cancer	0.000134	0.000617	CcSEcCtD
Fluticasone Propionate—Urticaria—Etoposide—lung cancer	0.000134	0.000617	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Etoposide—lung cancer	0.000133	0.000614	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Etoposide—lung cancer	0.000133	0.000614	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Doxorubicin—lung cancer	0.000133	0.000614	CcSEcCtD
Fluticasone Propionate—Eye disorder—Methotrexate—lung cancer	0.000133	0.000612	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Methotrexate—lung cancer	0.000132	0.000607	CcSEcCtD
Fluticasone Propionate—Urticaria—Paclitaxel—lung cancer	0.000131	0.000605	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Paclitaxel—lung cancer	0.000131	0.000602	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Paclitaxel—lung cancer	0.000131	0.000602	CcSEcCtD
Fluticasone Propionate—Epistaxis—Doxorubicin—lung cancer	0.000129	0.000595	CcSEcCtD
Fluticasone Propionate—Vomiting—Irinotecan—lung cancer	0.000129	0.000593	CcSEcCtD
Fluticasone Propionate—Sinusitis—Doxorubicin—lung cancer	0.000129	0.000592	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Methotrexate—lung cancer	0.000128	0.000591	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Methotrexate—lung cancer	0.000128	0.00059	CcSEcCtD
Fluticasone Propionate—Rash—Irinotecan—lung cancer	0.000128	0.000588	CcSEcCtD
Fluticasone Propionate—Dermatitis—Irinotecan—lung cancer	0.000128	0.000588	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000128	0.000588	CcSEcCtD
Fluticasone Propionate—Headache—Irinotecan—lung cancer	0.000127	0.000585	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Cisplatin—lung cancer	0.000126	0.00058	CcSEcCtD
Fluticasone Propionate—Vomiting—Gemcitabine—lung cancer	0.000125	0.000578	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Docetaxel—lung cancer	0.000125	0.000575	CcSEcCtD
Fluticasone Propionate—Betamethasone—ABCB1—lung cancer	0.000125	0.0266	CrCbGaD
Fluticasone Propionate—Mental disorder—Methotrexate—lung cancer	0.000124	0.000573	CcSEcCtD
Fluticasone Propionate—Rash—Gemcitabine—lung cancer	0.000124	0.000573	CcSEcCtD
Fluticasone Propionate—Dermatitis—Gemcitabine—lung cancer	0.000124	0.000573	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Etoposide—lung cancer	0.000124	0.000572	CcSEcCtD
Fluticasone Propionate—Erythema—Methotrexate—lung cancer	0.000124	0.00057	CcSEcCtD
Fluticasone Propionate—Malnutrition—Methotrexate—lung cancer	0.000124	0.00057	CcSEcCtD
Fluticasone Propionate—Headache—Gemcitabine—lung cancer	0.000124	0.000569	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Doxorubicin—lung cancer	0.000122	0.000564	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Doxorubicin—lung cancer	0.000122	0.000562	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Paclitaxel—lung cancer	0.000122	0.000561	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Doxorubicin—lung cancer	0.000121	0.000557	CcSEcCtD
Fluticasone Propionate—Nausea—Irinotecan—lung cancer	0.00012	0.000554	CcSEcCtD
Fluticasone Propionate—Pain—Docetaxel—lung cancer	0.00012	0.000552	CcSEcCtD
Fluticasone Propionate—Pruritus—Etoposide—lung cancer	0.000119	0.000549	CcSEcCtD
Fluticasone Propionate—Nausea—Gemcitabine—lung cancer	0.000117	0.00054	CcSEcCtD
Fluticasone Propionate—Vomiting—Cisplatin—lung cancer	0.000117	0.000539	CcSEcCtD
Fluticasone Propionate—Pruritus—Paclitaxel—lung cancer	0.000117	0.000538	CcSEcCtD
Fluticasone Propionate—Vision blurred—Methotrexate—lung cancer	0.000117	0.000537	CcSEcCtD
Fluticasone Propionate—Rash—Cisplatin—lung cancer	0.000116	0.000534	CcSEcCtD
Fluticasone Propionate—Dermatitis—Cisplatin—lung cancer	0.000116	0.000534	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Docetaxel—lung cancer	0.000115	0.000532	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Etoposide—lung cancer	0.000115	0.000531	CcSEcCtD
Fluticasone Propionate—Eye disorder—Doxorubicin—lung cancer	0.000115	0.00053	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Methotrexate—lung cancer	0.000115	0.000529	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Docetaxel—lung cancer	0.000114	0.000527	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Doxorubicin—lung cancer	0.000114	0.000526	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Paclitaxel—lung cancer	0.000113	0.000521	CcSEcCtD
Fluticasone Propionate—Malaise—Methotrexate—lung cancer	0.000111	0.000514	CcSEcCtD
Fluticasone Propionate—Dizziness—Etoposide—lung cancer	0.000111	0.000513	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Doxorubicin—lung cancer	0.000111	0.000512	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Doxorubicin—lung cancer	0.000111	0.000511	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Docetaxel—lung cancer	0.000111	0.00051	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Docetaxel—lung cancer	0.000111	0.00051	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Doxorubicin—lung cancer	0.00011	0.000506	CcSEcCtD
Fluticasone Propionate—Dizziness—Paclitaxel—lung cancer	0.000109	0.000503	CcSEcCtD
Fluticasone Propionate—Nausea—Cisplatin—lung cancer	0.000109	0.000503	CcSEcCtD
Fluticasone Propionate—Cough—Methotrexate—lung cancer	0.000108	0.000497	CcSEcCtD
Fluticasone Propionate—Mental disorder—Doxorubicin—lung cancer	0.000108	0.000496	CcSEcCtD
Fluticasone Propionate—Vomiting—Etoposide—lung cancer	0.000107	0.000494	CcSEcCtD
Fluticasone Propionate—Malnutrition—Doxorubicin—lung cancer	0.000107	0.000493	CcSEcCtD
Fluticasone Propionate—Erythema—Doxorubicin—lung cancer	0.000107	0.000493	CcSEcCtD
Fluticasone Propionate—Rash—Etoposide—lung cancer	0.000106	0.000489	CcSEcCtD
Fluticasone Propionate—Dermatitis—Etoposide—lung cancer	0.000106	0.000489	CcSEcCtD
Fluticasone Propionate—Headache—Etoposide—lung cancer	0.000106	0.000486	CcSEcCtD
Fluticasone Propionate—Arthralgia—Methotrexate—lung cancer	0.000105	0.000485	CcSEcCtD
Fluticasone Propionate—Chest pain—Methotrexate—lung cancer	0.000105	0.000485	CcSEcCtD
Fluticasone Propionate—Vomiting—Paclitaxel—lung cancer	0.000105	0.000484	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000105	0.000482	CcSEcCtD
Fluticasone Propionate—Rash—Paclitaxel—lung cancer	0.000104	0.00048	CcSEcCtD
Fluticasone Propionate—Dermatitis—Paclitaxel—lung cancer	0.000104	0.000479	CcSEcCtD
Fluticasone Propionate—Discomfort—Methotrexate—lung cancer	0.000104	0.000479	CcSEcCtD
Fluticasone Propionate—Headache—Paclitaxel—lung cancer	0.000103	0.000477	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Docetaxel—lung cancer	0.000103	0.000475	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Doxorubicin—lung cancer	0.000103	0.000474	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Methotrexate—lung cancer	0.000101	0.000465	CcSEcCtD
Fluticasone Propionate—Vision blurred—Doxorubicin—lung cancer	0.000101	0.000465	CcSEcCtD
Fluticasone Propionate—Infection—Methotrexate—lung cancer	0.0001	0.000462	CcSEcCtD
Fluticasone Propionate—Nausea—Etoposide—lung cancer	0.0001	0.000461	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Doxorubicin—lung cancer	9.93e-05	0.000458	CcSEcCtD
Fluticasone Propionate—Pruritus—Docetaxel—lung cancer	9.9e-05	0.000456	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Methotrexate—lung cancer	9.9e-05	0.000456	CcSEcCtD
Fluticasone Propionate—Agitation—Doxorubicin—lung cancer	9.84e-05	0.000453	CcSEcCtD
Fluticasone Propionate—Nausea—Paclitaxel—lung cancer	9.81e-05	0.000452	CcSEcCtD
Fluticasone Propionate—Skin disorder—Methotrexate—lung cancer	9.8e-05	0.000452	CcSEcCtD
Fluticasone Propionate—Malaise—Doxorubicin—lung cancer	9.65e-05	0.000445	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Docetaxel—lung cancer	9.58e-05	0.000441	CcSEcCtD
Fluticasone Propionate—Palpitations—Doxorubicin—lung cancer	9.46e-05	0.000436	CcSEcCtD
Fluticasone Propionate—Cough—Doxorubicin—lung cancer	9.34e-05	0.00043	CcSEcCtD
Fluticasone Propionate—Dizziness—Docetaxel—lung cancer	9.26e-05	0.000427	CcSEcCtD
Fluticasone Propionate—Hypertension—Doxorubicin—lung cancer	9.24e-05	0.000426	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Methotrexate—lung cancer	9.19e-05	0.000424	CcSEcCtD
Fluticasone Propionate—Arthralgia—Doxorubicin—lung cancer	9.11e-05	0.00042	CcSEcCtD
Fluticasone Propionate—Chest pain—Doxorubicin—lung cancer	9.11e-05	0.00042	CcSEcCtD
Fluticasone Propionate—Anxiety—Doxorubicin—lung cancer	9.08e-05	0.000419	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	9.05e-05	0.000417	CcSEcCtD
Fluticasone Propionate—Discomfort—Doxorubicin—lung cancer	9.01e-05	0.000415	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Methotrexate—lung cancer	9e-05	0.000415	CcSEcCtD
Fluticasone Propionate—Dry mouth—Doxorubicin—lung cancer	8.91e-05	0.000411	CcSEcCtD
Fluticasone Propionate—Vomiting—Docetaxel—lung cancer	8.9e-05	0.00041	CcSEcCtD
Fluticasone Propionate—Rash—Docetaxel—lung cancer	8.83e-05	0.000407	CcSEcCtD
Fluticasone Propionate—Dermatitis—Docetaxel—lung cancer	8.82e-05	0.000406	CcSEcCtD
Fluticasone Propionate—Headache—Docetaxel—lung cancer	8.77e-05	0.000404	CcSEcCtD
Fluticasone Propionate—Oedema—Doxorubicin—lung cancer	8.74e-05	0.000403	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Doxorubicin—lung cancer	8.74e-05	0.000403	CcSEcCtD
Fluticasone Propionate—Infection—Doxorubicin—lung cancer	8.68e-05	0.0004	CcSEcCtD
Fluticasone Propionate—Pain—Methotrexate—lung cancer	8.63e-05	0.000398	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Doxorubicin—lung cancer	8.57e-05	0.000395	CcSEcCtD
Fluticasone Propionate—Dexamethasone—PTGS2—lung cancer	8.53e-05	0.0182	CrCbGaD
Fluticasone Propionate—Tachycardia—Doxorubicin—lung cancer	8.53e-05	0.000393	CcSEcCtD
Fluticasone Propionate—Skin disorder—Doxorubicin—lung cancer	8.49e-05	0.000391	CcSEcCtD
Fluticasone Propionate—Nausea—Docetaxel—lung cancer	8.32e-05	0.000383	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Methotrexate—lung cancer	8.32e-05	0.000383	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Methotrexate—lung cancer	8.25e-05	0.00038	CcSEcCtD
Fluticasone Propionate—Urticaria—Methotrexate—lung cancer	8.02e-05	0.000369	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Methotrexate—lung cancer	7.98e-05	0.000368	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Methotrexate—lung cancer	7.98e-05	0.000368	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Doxorubicin—lung cancer	7.96e-05	0.000367	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Doxorubicin—lung cancer	7.79e-05	0.000359	CcSEcCtD
Fluticasone Propionate—Pain—Doxorubicin—lung cancer	7.47e-05	0.000344	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Methotrexate—lung cancer	7.43e-05	0.000343	CcSEcCtD
Fluticasone Propionate—Dexamethasone—ABCB1—lung cancer	7.25e-05	0.0155	CrCbGaD
Fluticasone Propionate—Feeling abnormal—Doxorubicin—lung cancer	7.2e-05	0.000332	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Doxorubicin—lung cancer	7.14e-05	0.000329	CcSEcCtD
Fluticasone Propionate—Pruritus—Methotrexate—lung cancer	7.14e-05	0.000329	CcSEcCtD
Fluticasone Propionate—Urticaria—Doxorubicin—lung cancer	6.94e-05	0.00032	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Doxorubicin—lung cancer	6.91e-05	0.000318	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Doxorubicin—lung cancer	6.91e-05	0.000318	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Methotrexate—lung cancer	6.9e-05	0.000318	CcSEcCtD
Fluticasone Propionate—Dizziness—Methotrexate—lung cancer	6.67e-05	0.000307	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Doxorubicin—lung cancer	6.44e-05	0.000297	CcSEcCtD
Fluticasone Propionate—Vomiting—Methotrexate—lung cancer	6.42e-05	0.000296	CcSEcCtD
Fluticasone Propionate—Rash—Methotrexate—lung cancer	6.36e-05	0.000293	CcSEcCtD
Fluticasone Propionate—Dermatitis—Methotrexate—lung cancer	6.36e-05	0.000293	CcSEcCtD
Fluticasone Propionate—Headache—Methotrexate—lung cancer	6.32e-05	0.000291	CcSEcCtD
Fluticasone Propionate—Pruritus—Doxorubicin—lung cancer	6.18e-05	0.000285	CcSEcCtD
Fluticasone Propionate—Nausea—Methotrexate—lung cancer	5.99e-05	0.000276	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Doxorubicin—lung cancer	5.98e-05	0.000275	CcSEcCtD
Fluticasone Propionate—Dizziness—Doxorubicin—lung cancer	5.78e-05	0.000266	CcSEcCtD
Fluticasone Propionate—Vomiting—Doxorubicin—lung cancer	5.56e-05	0.000256	CcSEcCtD
Fluticasone Propionate—Rash—Doxorubicin—lung cancer	5.51e-05	0.000254	CcSEcCtD
Fluticasone Propionate—Dermatitis—Doxorubicin—lung cancer	5.5e-05	0.000254	CcSEcCtD
Fluticasone Propionate—Headache—Doxorubicin—lung cancer	5.47e-05	0.000252	CcSEcCtD
Fluticasone Propionate—Nausea—Doxorubicin—lung cancer	5.19e-05	0.000239	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—POMC—lung cancer	2.16e-05	0.00016	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GSTM1—lung cancer	2.16e-05	0.00016	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKR1C1—lung cancer	2.13e-05	0.000158	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STK11—lung cancer	2.12e-05	0.000157	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL6R—lung cancer	2.11e-05	0.000156	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ATP5H—lung cancer	2.1e-05	0.000155	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—POMC—lung cancer	2.09e-05	0.000155	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—UGT1A1—lung cancer	2.07e-05	0.000153	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FOXO3—lung cancer	2.05e-05	0.000152	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP1A1—lung cancer	2.05e-05	0.000151	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ERBB3—lung cancer	2.03e-05	0.00015	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ERCC2—lung cancer	2.03e-05	0.00015	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—KRAS—lung cancer	2.01e-05	0.000149	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MAP2K1—lung cancer	2.01e-05	0.000149	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GNG11—lung cancer	2e-05	0.000148	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CD—lung cancer	1.99e-05	0.000148	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP2E1—lung cancer	1.99e-05	0.000147	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NQO1—lung cancer	1.96e-05	0.000145	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TERT—lung cancer	1.95e-05	0.000144	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AVP—lung cancer	1.92e-05	0.000142	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALDOA—lung cancer	1.9e-05	0.000141	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FGFR1—lung cancer	1.89e-05	0.00014	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PLBD1—lung cancer	1.87e-05	0.000138	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HIF1A—lung cancer	1.86e-05	0.000138	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF1R—lung cancer	1.85e-05	0.000137	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ERCC2—lung cancer	1.85e-05	0.000137	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PIK3CA—lung cancer	1.85e-05	0.000137	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NCOA3—lung cancer	1.85e-05	0.000137	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HES1—lung cancer	1.82e-05	0.000134	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APOA1—lung cancer	1.8e-05	0.000133	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ADCY1—lung cancer	1.79e-05	0.000133	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ABCG2—lung cancer	1.79e-05	0.000133	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—lung cancer	1.79e-05	0.000132	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KDR—lung cancer	1.78e-05	0.000132	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—RAF1—lung cancer	1.78e-05	0.000132	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—STK11—lung cancer	1.77e-05	0.000131	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ENO2—lung cancer	1.76e-05	0.00013	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HPGDS—lung cancer	1.76e-05	0.00013	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—APOA1—lung cancer	1.76e-05	0.00013	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPP2R1B—lung cancer	1.75e-05	0.000129	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CB—lung cancer	1.74e-05	0.000129	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HSD17B10—lung cancer	1.71e-05	0.000126	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—HRAS—lung cancer	1.71e-05	0.000126	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTT1—lung cancer	1.71e-05	0.000126	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GCLC—lung cancer	1.69e-05	0.000125	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP2A6—lung cancer	1.69e-05	0.000125	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.68e-05	0.000124	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CXCL8—lung cancer	1.67e-05	0.000124	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—MYC—lung cancer	1.67e-05	0.000123	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ERBB3—lung cancer	1.66e-05	0.000123	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CG—lung cancer	1.64e-05	0.000121	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APC—lung cancer	1.64e-05	0.000121	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KIT—lung cancer	1.64e-05	0.000121	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTP1—lung cancer	1.64e-05	0.000121	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGF—lung cancer	1.62e-05	0.00012	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CG—lung cancer	1.6e-05	0.000119	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ENO1—lung cancer	1.6e-05	0.000118	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL2—lung cancer	1.6e-05	0.000118	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CAT—lung cancer	1.59e-05	0.000118	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TERT—lung cancer	1.59e-05	0.000118	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CKB—lung cancer	1.59e-05	0.000118	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—AKT1—lung cancer	1.58e-05	0.000117	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—POMC—lung cancer	1.56e-05	0.000116	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ABCB1—lung cancer	1.55e-05	0.000115	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGFR1—lung cancer	1.54e-05	0.000114	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—BRAF—lung cancer	1.54e-05	0.000114	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—POMC—lung cancer	1.53e-05	0.000113	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6R—lung cancer	1.52e-05	0.000113	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—TYMS—lung cancer	1.52e-05	0.000113	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HIF1A—lung cancer	1.52e-05	0.000113	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CREBBP—lung cancer	1.52e-05	0.000113	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT1—lung cancer	1.51e-05	0.000112	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTM1—lung cancer	1.5e-05	0.000111	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTM2—lung cancer	1.49e-05	0.000111	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CNDP2—lung cancer	1.49e-05	0.000111	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CREBBP—lung cancer	1.49e-05	0.00011	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APOA1—lung cancer	1.47e-05	0.000109	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KDR—lung cancer	1.45e-05	0.000108	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTMR3—lung cancer	1.45e-05	0.000108	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAP2K1—lung cancer	1.45e-05	0.000107	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CD—lung cancer	1.44e-05	0.000107	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP2E1—lung cancer	1.43e-05	0.000106	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MAPK3—lung cancer	1.43e-05	0.000106	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP1A1—lung cancer	1.43e-05	0.000106	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NQO1—lung cancer	1.42e-05	0.000105	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PGAM1—lung cancer	1.42e-05	0.000105	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ERCC2—lung cancer	1.41e-05	0.000105	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CD—lung cancer	1.41e-05	0.000104	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ALB—lung cancer	1.39e-05	0.000103	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MYC—lung cancer	1.39e-05	0.000103	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—CREBBP—lung cancer	1.35e-05	0.0001	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP2A7—lung cancer	1.35e-05	0.0001	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CG—lung cancer	1.34e-05	9.92e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APC—lung cancer	1.34e-05	9.92e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KIT—lung cancer	1.34e-05	9.92e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—NRAS—lung cancer	1.34e-05	9.92e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGF—lung cancer	1.32e-05	9.8e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SDC4—lung cancer	1.32e-05	9.78e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MDM2—lung cancer	1.29e-05	9.56e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RAF1—lung cancer	1.29e-05	9.53e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MAPK3—lung cancer	1.28e-05	9.5e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—STK11—lung cancer	1.28e-05	9.46e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—POMC—lung cancer	1.28e-05	9.44e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ERBB2—lung cancer	1.27e-05	9.43e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—BRAF—lung cancer	1.26e-05	9.32e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CB—lung cancer	1.26e-05	9.3e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MTOR—lung cancer	1.26e-05	9.3e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6R—lung cancer	1.24e-05	9.21e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CREBBP—lung cancer	1.24e-05	9.2e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CB—lung cancer	1.23e-05	9.09e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—APOA1—lung cancer	1.22e-05	9.06e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—EGFR—lung cancer	1.22e-05	9.04e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—lung cancer	1.22e-05	9.01e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCL8—lung cancer	1.21e-05	8.94e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—RRM1—lung cancer	1.2e-05	8.91e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTA3—lung cancer	1.2e-05	8.91e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAP2K1—lung cancer	1.19e-05	8.78e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTP1—lung cancer	1.18e-05	8.76e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CD—lung cancer	1.18e-05	8.72e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CASP3—lung cancer	1.16e-05	8.56e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL2—lung cancer	1.15e-05	8.54e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—KRAS—lung cancer	1.15e-05	8.54e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CAT—lung cancer	1.15e-05	8.52e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—B4GALT5—lung cancer	1.13e-05	8.38e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCND1—lung cancer	1.13e-05	8.33e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—JUN—lung cancer	1.12e-05	8.31e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ABCB1—lung cancer	1.12e-05	8.29e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CG—lung cancer	1.12e-05	8.27e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTA4—lung cancer	1.1e-05	8.15e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TYMS—lung cancer	1.1e-05	8.14e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MMP9—lung cancer	1.09e-05	8.09e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1A—lung cancer	1.09e-05	8.06e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTM1—lung cancer	1.09e-05	8.05e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTEN—lung cancer	1.09e-05	8.04e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTA2—lung cancer	1.07e-05	7.94e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—POMC—lung cancer	1.06e-05	7.87e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTEN—lung cancer	1.06e-05	7.85e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CA—lung cancer	1.06e-05	7.84e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MDM2—lung cancer	1.06e-05	7.81e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RAF1—lung cancer	1.05e-05	7.78e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ERBB2—lung cancer	1.04e-05	7.7e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EP300—lung cancer	1.04e-05	7.67e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CREBBP—lung cancer	1.04e-05	7.66e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTA1—lung cancer	1.04e-05	7.66e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP1A1—lung cancer	1.03e-05	7.63e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MTOR—lung cancer	1.03e-05	7.6e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CB—lung cancer	1.03e-05	7.6e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCC3—lung cancer	1.02e-05	7.58e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ERCC2—lung cancer	1.02e-05	7.57e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—EP300—lung cancer	1.01e-05	7.49e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SRC—lung cancer	1.01e-05	7.46e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKR1C1—lung cancer	9.91e-06	7.34e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCL8—lung cancer	9.87e-06	7.3e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CD—lung cancer	9.82e-06	7.27e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—lung cancer	9.81e-06	7.26e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—HRAS—lung cancer	9.81e-06	7.26e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STAT3—lung cancer	9.72e-06	7.19e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALB—lung cancer	9.69e-06	7.17e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NRAS—lung cancer	9.69e-06	7.17e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AKT1—lung cancer	9.63e-06	7.13e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—UGT1A1—lung cancer	9.62e-06	7.12e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CASP3—lung cancer	9.45e-06	6.99e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL2—lung cancer	9.43e-06	6.98e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL6—lung cancer	9.38e-06	6.95e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK3—lung cancer	9.28e-06	6.87e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GNG11—lung cancer	9.28e-06	6.87e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCND1—lung cancer	9.19e-06	6.8e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—JUN—lung cancer	9.18e-06	6.79e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MYC—lung cancer	9.03e-06	6.68e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MMP9—lung cancer	8.93e-06	6.61e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1A—lung cancer	8.89e-06	6.58e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTEN—lung cancer	8.87e-06	6.57e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APOA1—lung cancer	8.84e-06	6.55e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALDOA—lung cancer	8.84e-06	6.54e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGFR—lung cancer	8.83e-06	6.54e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT1—lung cancer	8.66e-06	6.41e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NCOA3—lung cancer	8.58e-06	6.35e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CB—lung cancer	8.56e-06	6.33e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—lung cancer	8.48e-06	6.28e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EP300—lung cancer	8.46e-06	6.26e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ADCY1—lung cancer	8.34e-06	6.18e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCG2—lung cancer	8.34e-06	6.18e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KRAS—lung cancer	8.34e-06	6.17e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MAPK3—lung cancer	8.25e-06	6.11e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SRC—lung cancer	8.23e-06	6.09e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ENO2—lung cancer	8.18e-06	6.06e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HPGDS—lung cancer	8.18e-06	6.06e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPP2R1B—lung cancer	8.13e-06	6.02e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CG—lung cancer	8.07e-06	5.98e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MYC—lung cancer	8.03e-06	5.94e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—lung cancer	8.02e-06	5.93e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTT1—lung cancer	7.94e-06	5.87e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STAT3—lung cancer	7.94e-06	5.87e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NRAS—lung cancer	7.92e-06	5.86e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GCLC—lung cancer	7.85e-06	5.81e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP2A6—lung cancer	7.85e-06	5.81e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—POMC—lung cancer	7.69e-06	5.69e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CA—lung cancer	7.66e-06	5.67e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK3—lung cancer	7.58e-06	5.61e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CA—lung cancer	7.49e-06	5.54e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CREBBP—lung cancer	7.49e-06	5.54e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ENO1—lung cancer	7.44e-06	5.5e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—lung cancer	7.41e-06	5.49e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTEN—lung cancer	7.4e-06	5.47e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MYC—lung cancer	7.38e-06	5.46e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGFR—lung cancer	7.21e-06	5.34e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CD—lung cancer	7.1e-06	5.25e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HRAS—lung cancer	7.09e-06	5.25e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—EP300—lung cancer	7.05e-06	5.22e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALB—lung cancer	7.01e-06	5.19e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KRAS—lung cancer	6.81e-06	5.04e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6—lung cancer	6.79e-06	5.02e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP2E1—lung cancer	6.67e-06	4.94e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NQO1—lung cancer	6.6e-06	4.88e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT1—lung cancer	6.26e-06	4.63e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CA—lung cancer	6.26e-06	4.63e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CB—lung cancer	6.19e-06	4.58e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—lung cancer	6.13e-06	4.54e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKT1—lung cancer	6.12e-06	4.53e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—lung cancer	6.06e-06	4.48e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—STK11—lung cancer	5.95e-06	4.4e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HRAS—lung cancer	5.79e-06	4.29e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AKT1—lung cancer	5.57e-06	4.12e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6—lung cancer	5.54e-06	4.1e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTP1—lung cancer	5.5e-06	4.07e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CAT—lung cancer	5.35e-06	3.96e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTEN—lung cancer	5.35e-06	3.96e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CA—lung cancer	5.22e-06	3.86e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCB1—lung cancer	5.21e-06	3.85e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TYMS—lung cancer	5.11e-06	3.79e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT1—lung cancer	5.11e-06	3.79e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—EP300—lung cancer	5.1e-06	3.77e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTM1—lung cancer	5.06e-06	3.74e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP1A1—lung cancer	4.79e-06	3.55e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ERCC2—lung cancer	4.75e-06	3.52e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKT1—lung cancer	4.26e-06	3.15e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APOA1—lung cancer	4.11e-06	3.04e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CA—lung cancer	3.77e-06	2.79e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CG—lung cancer	3.75e-06	2.78e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—POMC—lung cancer	3.57e-06	2.64e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CREBBP—lung cancer	3.48e-06	2.58e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CD—lung cancer	3.3e-06	2.44e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALB—lung cancer	3.26e-06	2.41e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKT1—lung cancer	3.08e-06	2.28e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CB—lung cancer	2.88e-06	2.13e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—lung cancer	2.85e-06	2.11e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTEN—lung cancer	2.49e-06	1.84e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—EP300—lung cancer	2.37e-06	1.75e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CA—lung cancer	1.75e-06	1.3e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKT1—lung cancer	1.43e-06	1.06e-05	CbGpPWpGaD
